瑞芬太尼用于分娩活跃晚期静脉自控镇痛的临床观察

目的:探讨瑞芬太尼静脉自控镇痛用于经产妇分娩活跃期晚期镇痛的可行性。方法:单胎头位足月经产妇自然分娩,选择进入第1产程活跃期晚期后自愿要求分娩镇痛产妇120例为观察组:行瑞芬太尼静脉镇痛(PCIA),同时选择同期常规产科处理经产妇自然分娩120例产妇作为对照组。观察两组产妇镇痛效果、呼吸循环指标等指标。结果:观察组镇痛效果显著优于对照组,P<0.05;两组产程、催产素应用率等比较,差异均无统计学意义(P>0.05);结论:瑞芬太尼静脉自控镇痛用于经产妇分娩活跃期晚期镇痛安全有效,不影响产程进展,对新生儿也无不良反应。

Objective:To investigate the feasibility of remifentanil for analgesia after maternity active phase controlled intravenous analgesia late.The method of single cephalic foot menstrual maternal natural childbirth,voluntarily chose to enter the requirements of paragraph 1 after the active phase of labor analgesia late maternal 120 cases of the observation group: Line remifentanil intravenous analgesia(PCIA), while selecting the same period conventional obstetric management 120 cases of maternal natural childbirth as women in the control group. Observed two groups of maternal analgesia, respiratory and circulatory indicators and other indicators.Results:There were significant analgesic effect than the control group,P<0.05; two sets of labor, oxytocin use rate, the difference was not statistically significant(P>0.05);Conclusion:remifentanil PCIA for late maternal active labor analgesia is safe and effective, does not affect the progress of labor, and no adverse effects on the newborn